“…Glycolysis is controlled by allosteric regulators, among which glucose 1,6-bisphosphate (Glc-1,6-P 2 ) plays a major role in extrahepatic tissues (reviewed in Beitner, 1979Beitner, , 1984Beitner, , 1985Beitner, , 1990, as well as by reversible binding of glycolytic enzymes to cytoskeleton (Arnold and Pette, 1968; reviewed in Clarke et al, 1985;Beitner, 1993;Pagliaro, 1993;Bereiter-Hahn et al, 1997). All glycolytic enzymes bind to cytoskeleton except hexokinase (EC 2.7.1.1), which binds reversibly to mitochondria, where it is linked to oxidative phosphorylation (Gots et al, 1972;Gots and Bessman, 1974;Viitanen et al, 1984;Wilson, 1985;Kottke et al, 1988;Adams et al, 1991). An increase in mitochondrially bound hexokinase was found in tumour cells and it has been suggested that this binding plays an important role in cancer cell metabolism (Arora and Pedersen, 1988;Fanciulli et al, 1994;reviewed in Golshani-Hebroni and Bessman, 1997).…”